Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,529 | 3,090 | 3,181 | 3,704 | 4,831 |
| Operating Income | -2,529 | -3,090 | -3,181 | -3,704 | -4,831 |
| Other Income | 1,591 | -272 | 2,799 | -1,056 | 547 |
| Pre-tax Income | -938 | -3,362 | -382 | -4,760 | -4,284 |
| Income Tax | N/A | N/A | -1,018 | -605 | -852 |
| Net Income Continuous | -938 | -3,362 | 636 | -4,155 | -3,432 |
| Net Income | $-938 | $-3,362 | $636 | $-4,155 | $-3,432 |
| EPS Basic Total Ops | -0.06 | -0.21 | 0.11 | -0.36 | -0.30 |
| EPS Basic Continuous Ops | -0.06 | -0.21 | 0.11 | -0.36 | -0.30 |
| EPS Diluted Total Ops | -0.06 | -0.21 | 0.11 | -0.36 | -0.30 |
| EPS Diluted Continuous Ops | -0.06 | -0.21 | 0.11 | -0.36 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.21 | -0.21 | -0.26 | -0.33 |
| EBITDA(a) | $-2,529 | $-3,088 | $-3,179 | $-3,702 | $-4,829 |